Immune checkpoint inhibitors: new strategies to checkmate cancer.

about

Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma.Gut microbiome modulates efficacy of immune checkpoint inhibitors.Targeting adenosine for cancer immunotherapy.Predictors of immunotherapy-induced immune-related adverse events

P2860

Q55008075-5DAE813A-E323-4AE4-8EC4-29609A910BAF Q55240704-379A2F5E-1E5A-4697-B11B-26D703BB867B Q55330380-6813EDF9-04C3-4777-AB32-0E11FC382CFE Q59135410-ABA896DE-E7ED-428D-B5AC-7E09661DF4AF

P2860

Immune checkpoint inhibitors: new strategies to checkmate cancer.

Item

http://www.wikidata.org/entity/Q47400647

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@en

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@nl

type

Item

label

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@en

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@nl

prefLabel

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@en

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@nl

P1476

Immune checkpoint inhibitors: new strategies to checkmate cancer.

@en

P2093

R A M Wilson

http://www.w3.org/2001/XMLSchema#string

T R J Evans

http://www.w3.org/2001/XMLSchema#string

P2860

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

Viral immune evasion due to persistence of activated T cells without effector function

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

P304

133-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEI.13081

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Nibbs

Alasdair R Fraser

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29139554

http://www.w3.org/2001/XMLSchema#string

P932

5758374

http://www.w3.org/2001/XMLSchema#string

Immune checkpoint inhibitors: new strategies to checkmate cancer.

about

P2860

P2860

Immune checkpoint inhibitors: new strategies to checkmate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932